5 days ago
Nationwide Soap Recall Issued Over Contamination Linked to Sepsis
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
DermaRite Industries has voluntarily recalled specific lots of its products nationwide due to contamination with Burkholderia cepacia, a bacterium that can cause serious infections in immunocompromised individuals.
The products include DermaKleen, Dermasarra, Kleenfoam, and Perigiene items.
Newsweek contacted DermaRite Industries for comment via online form on Sunday.
Why It Matters
Burkholderia cepacia is a group of bacteria commonly found in soil and water. While it typically poses little risk to healthy individuals, it can lead to life-threatening infections, including sepsis, in those with weakened immune systems. The affected products were distributed across the United States and Puerto Rico.
Stock image of a person using a liquid soap dispenser.
Stock image of a person using a liquid soap To Know
The products are commonly used in health care settings for handwashing and skin care. The recalled products, as per the company recall notice, are:
Product Description Reorder # Lot Number Expiration Date DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30586A 7/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30586B 7/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30626A 7/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30628A 8/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30657A 8/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30741A 7/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 30871A 10/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 40002A 12/2025 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 40012A 1/2026 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 40301A 3/2026 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 40789A 9/2026 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 50068B 1/2027 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 50144A 2/2027 DermaKleen 1000ml. bag-n-box, 10/case 0092BB 50149A 2/2027 DermaKleen 800ml. bag-n-box, 12/case 0090BB 30550A 7/2025 DermaKleen 800ml. bag-n-box, 12/case 0090BB 30670A 8/2025 DermaKleen 800ml. bag-n-box, 12/case 0090BB 30682A 8/2025 DermaKleen 800ml. bag-n-box, 12/case 0090BB 40025A 1/2026 DermaKleen 800ml. bag-n-box, 12/case 0090BB 40375A 4/2026 DermaKleen 800ml. bag-n-box, 12/case 0090BB 40427A 5/2026 DermaKleen 800ml. bag-n-box, 12/case 0090BB 40436A 5/2026 DermaKleen 800ml. bag-n-box, 12/case 0090BB 50068A 1/2027 DermaSarra 7.5oz, 24/case 00188 40187.2 2/2026 KleenFoam 1000ml., 6/case 0093F 30705A 8/2025 KleenFoam 1000ml., 6/case 0093F 30771A 9/2025 KleenFoam 1000ml., 6/case 0093F 30920A 10/2025 KleenFoam 1000ml., 6/case 0093F 40016A 1/2026 KleenFoam 1000ml., 6/case 0093F 40303A 4/2026 KleenFoam 1000ml., 6/case 0093F 40428A 5/2026 KleenFoam 1000ml., 6/case 0093F 40505A 6/2026 KleenFoam 1000ml., 6/case 0093F 41053C 12/2026 KleenFoam 1000ml., 6/case 0093F 41053A 12/2026 KleenFoam 1000ml., 6/case 0093F 41053B 12/2026 KleenFoam 1000ml., 6/case 0093F 50017A 1/2027 PeriGiene 7.5oz., 48/case 00198 31013A 11/2025 PeriGiene 7.5oz., 48/case 00198 40345A 4/2026 PeriGiene 7.5oz., 48/case 00198 40355A 4/2026 PeriGiene 7.5oz., 48/case 00198 40571A 6/2026 PeriGiene 7.5oz., 48/case 00198 40580A 6/2026 PeriGiene 7.5oz., 48/case 00198 40587A 7/2026 PeriGiene 7.5oz., 48/case 00198 40591A 7/2026 PeriGiene 7.5oz., 48/case 00198 40870.1 10/2026 PeriGiene 7.5oz., 48/case 00198 40877.1 10/2026 PeriGiene 7.5oz., 48/case 00198 41093A 12/2026 PeriGiene 7.5oz., 48/case 00198 50072A 1/2027 PeriGiene 7.5oz., 48/case 00198 50079A 1/2027
A full list of recalled products and product labels is also provided on the Food and Drug Administration's website here.
What People Are Saying
Recall notice risk statement on the DermaRite website: "Burkholderia cepacia complex in these products may result in serious and life-threatening infections. The contaminated products may be used by immunosuppressed individuals or by people attending to immunosuppressed individuals.
"In healthy individuals with minor skin lesions, the use of the product will more likely result in local infections, whereas in immunocompromised individuals the infection is more likely to spread into [the] blood stream leading to life-threatening sepsis. To date, DermaRite has not received any reports of adverse events related to this recall."
What Happens Next
Individuals using these products, especially those with compromised immune systems, should discontinue use immediately.
The company advises that consumers should contact their physician or health care provider if they have experienced any problems that may be related to using this product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.
Complete and submit the report online:
Mail or fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Consumers with questions regarding this recall can call DermaRite on 973-569-9000 x104 Monday through Friday, 9 a.m.—5 p.m. ET, email or visit the official website.
